Log in to save to my catalogue

PLK1 inhibition dampens NLRP3 inflammasome–elicited response in inflammatory disease models

PLK1 inhibition dampens NLRP3 inflammasome–elicited response in inflammatory disease models

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9ec59b6ac22e465f89c2f85931f35cac

PLK1 inhibition dampens NLRP3 inflammasome–elicited response in inflammatory disease models

About this item

Full title

PLK1 inhibition dampens NLRP3 inflammasome–elicited response in inflammatory disease models

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2023-11, Vol.133 (21), p.1-16

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Unabated activation of the NLR family pyrin domain-containing 3 (NLRP3) inflammasome is linked with the pathogenesis of various inflammatory disorders. Polo-like kinase 1 (PLK1) has been widely studied for its role in mitosis. Here, using both pharmacological and genetic approaches, we demonstrate that PLK1 promoted NLRP3 inflammasome activation at...

Alternative Titles

Full title

PLK1 inhibition dampens NLRP3 inflammasome–elicited response in inflammatory disease models

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9ec59b6ac22e465f89c2f85931f35cac

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9ec59b6ac22e465f89c2f85931f35cac

Other Identifiers

ISSN

1558-8238,0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI162129

How to access this item